Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wasif Ahmed Khan"'
Autor:
Saeed Ahmed, Ayaz ur Rehman, Zainab Bibi, Sundus Iftikhar, Maleeha Raza, Hafiz Mohammad Amir Yousuf, Fizzah Naz, Syed Adil Mir Shah, Syeda Lamiya Mir, Ayesha Bibi, Wasif Ahmed Khan, Muhammad Sohail Salat, Gul Ambreen, Kashif Hussain
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background With a wide therapeutic index, efficacy, ease of use, and other neuroprotective and respiratory benefits, caffeine citrate(CC) is currently the drug of choice for preterm neonates (PTNs). Caffeine-induced excessive energy expendit
Externí odkaz:
https://doaj.org/article/ed94d6ae401f4c5bbd15865770e51fd0
Autor:
Ijaz Hussain, Manoj Kumar, Amin Ali, Fizzah Naz, Wasif Ahmed Khan, Muhammad Sohail Salat, Shahzad Rauf, Gul Ambreen, Kashif Hussain
Publikováno v:
Dose-Response, Vol 22 (2024)
Background Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC
Externí odkaz:
https://doaj.org/article/27180460c89d47f78269fa0aa01b8d62
Autor:
Kashif Hussain, Muhammad Sohail Salat, Shahzad Rauf, Manoj Rathi, Midhat Khan, Fizzah Naz, Wasif Ahmed Khan, Rahila Ikram, Gul Ambreen
Publikováno v:
BMC Pharmacology and Toxicology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Anecdotal experience and studies have shown that most pediatric patients fail to reach target therapeutic vancomycin trough levels (VTLs) and required higher total daily doses (TDD). This retrospective study aims to evaluate the f
Externí odkaz:
https://doaj.org/article/8534951458ea42beb47dbb2b12aa625b
Autor:
Manoj Kumar, Amin Ali, Muhammad Azeem Khan, Sadia Sohail, Syed Muzafar Saleem, Midhat Khan, Fizzah Naz, Wasif Ahmed Khan, Muhammad Sohail Salat, Kashif Hussain, Gul Ambreen
Publikováno v:
BMC Pediatrics, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Caffeine is a routinely prescribed pharmacological active compound in neonatal intensive care units (NICU) for treating apnea of prematurity (AOP), which also decreases the risk of bronchopulmonary dysplasia and cerebral palsy in
Externí odkaz:
https://doaj.org/article/3ed4821964d8419e9548d5907fd9b164
Autor:
Kashif Hussain, Muhammad Sohail Salat, Shahzad Rauf, Manoj Rathi, Midhat Khan, Fizzah Naz, Wasif Ahmed Khan, Rahila Ikram, Gul Ambreen
Publikováno v:
BMC pharmacologytoxicology. 23(1)
Background Anecdotal experience and studies have shown that most pediatric patients fail to reach target therapeutic vancomycin trough levels (VTLs) and required higher total daily doses (TDD). This retrospective study aims to evaluate the frequency